Lawsuit over failed follow-up for CT findings settled out of court

A lawsuit alleging hospital staff failed to provide reasonable care to treat a patient’s suspicious mass on her left kidney identified on a CT scan has been settled out of court, according to reporting from the Brattleboro Reformer.

Cynthia Hawthorne filed the suit against Brattleboro Memorial Hospital in Vermont, Windham Radiology Associated and Dartmouth-Hitchcock Clinic in May 2017. She claimed a radiologist recommended biopsy and follow-up with a urologist for a mass “highly suspicious for a renal cell carcinoma (cancer),” the Reformer reported. But that follow-up never happened and Hawthorne was discharged.

She was finally notified of the findings two-and-a-half years later, but the cancer had already spread to her lungs; she died on Feb. 7.

Brattleboro Memorial Hospital received two citations related to the incident and submitted a plan of correction that was accepted by the Division of Licensing and Protection.

"It is hereby ordered that this action is hereby dismissed, without costs, with the right to petition, upon good cause shown within 60 days, to reopen the action if settlement is not consummated," Judge William K. Sessions III wrote in a decision issued on Sept. 24.

Read the entire story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.